Hims & Hers Health, Inc. (HIMS) vs Dr. Reddy's Laboratories Ltd (RDY)
- Hims & Hers Health, Inc. HIMS 28.07 −4.46%
- Dr. Reddy's Laboratories Ltd RDY 13.05 +1.16%
Hims & Hers Health, Inc. and Dr. Reddy's Laboratories Ltd are both Drug Manufacturers Specialty & Generic companies. Dr. Reddy's Laboratories Ltd is the larger, with a market value of $10.7B against $6.9B — 1.6× the size. Hims & Hers Health, Inc. has negative trailing earnings, so its P/E is not meaningful; Dr. Reddy's Laboratories Ltd trades at 32.9×. Hims & Hers Health, Inc. grew revenue faster over the last twelve months: 28.0% against −11.6%. Dr. Reddy's Laboratories Ltd has the higher net margin (9.81% vs −5.51%) and the higher return on invested capital (5.89% vs −11.4%). Across the 20 metrics below, Dr. Reddy's Laboratories Ltd leads on 14 and Hims & Hers Health, Inc. on 6.
Valuation
Profitability
| Metric | HIMS | RDY | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 68.43% | 50.00% | 53.94% |
| Operating margin | (5.99%) | 10.91% | 0.00% |
| Net margin | (5.51%) | 9.81% | 0.00% |
| Free cash flow margin | 3.22% | 4.05% | 0.00% |
| Return on equity | (32.03%) | 8.21% | (0.40%) |
| Return on assets | (5.16%) | 5.55% | (3.32%) |
| Return on invested capital | (11.38%) | 5.89% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack